-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
F-star Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2021.
- F-star Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$13.7M, a 42.8% decline year-over-year.
- F-star Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$36.8M, a 16.5% increase year-over-year.
- F-star Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$30.7M, a 37.2% decline from 2020.
- F-star Therapeutics, Inc. annual Operating Income (Loss) for 2020 was -$22.4M, a 0.5% increase from 2019.
- F-star Therapeutics, Inc. annual Operating Income (Loss) for 2019 was -$22.5M, a 21% increase from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)